TruAlt Bioenergy IPO Launches Today: Priced Aggressively at ₹472-496 per Share

TruAlt Bioenergy storms public markets with ambitious pricing strategy.
Testing investor appetite
The bioenergy firm positions itself at ₹472-496 per share—betting big on renewable energy demand. Market watchers eye whether retail investors will bite at this premium valuation.
Sector momentum play
Bioenergy stocks ride green wave as climate commitments intensify. TruAlt's timing capitalizes on ESG frenzy—though skeptics note another 'sustainable' play hitting markets right when clean tech valuations peak.
Another day, another company trying to convince investors they're saving the planet while really just saving their balance sheets.